Archean

Archean, presented publicly as Archean Sciences, is a neurotechnology company building engineered biological systems based on living brain cells. Its stated approach is to program living neurons into what it calls synthetic neurocomputers and to learn their signaling behavior through continuous, controlled experimentation rather than observation alone. The company frames the brain as too complex to understand through observation, positioning cell-level engineering of biology as its core method.

The company describes two coupled components. "aris" is its intelligence system, and a "Discovery Engine" is an autonomous laboratory. Archean describes these as operating recursively: the intelligence system determines what to build and test, and the resulting experimental discoveries improve the intelligence that directs subsequent work. Its technology platform is said to capture three dimensions of neural systems — molecular state, cellular structure, and network function.

Archean identifies three intended application areas: therapeutic discovery for brain disorders, next-generation computing built with living neurons, and neural interfaces for communicating with the nervous system.

Founding story

The company's name derives from the Greek noun archē, meaning first principle, origin or beginning, and from the Archean Eon, the period roughly four billion years ago associated with the emergence of life on Earth.

Latest developments

Archean lists two founders — Austin Ellis-Mohr, Ph.D., Chief Executive Officer, whose affiliations include Cornell, the Flatiron Institute, the White House Office of Science and Technology Policy and UIUC; and Mattia Gazzola, Ph.D., Chief Scientific Officer, with affiliations including ETH Zurich, Harvard, Caltech, MIT and UIUC. It also lists two advisors: Lav Varshney, Ph.D. (Cornell, MIT, IBM, Salesforce, UIUC, White House, Stony Brook) and Gene Robinson, Ph.D. (Cornell, UIUC, Discovery Partners Institute).